FDA widens meningitis drug warnings, CFPB pursues rules on reverse mortgages, and more.
- The Food and Drug Administration (FDA) warned patients and physicians that the drug company connected to the meningitis outbreak may be linked to new reports of contamination.
- Scientific methods used by the Environmental Protection Agency (EPA) to test a gas-drilling site have come under scrutiny by an oil group.
- The Consumer Financial Protection Bureau (CFPB) expressed concern that mortgage policies intended to help seniors may be subjecting some to financial abuse.
- JP Morgan’s energy-trading unit admitted error in an apology to the Federal Energy Regulatory Commission (FERC).
- A federal appeals court in New York struck down the Defense of Marriage Act (DOMA).
- The Federal Trade Commission (FTC) published guidelines for the use of environmental marketing claims. See related The Regulatory Review essay.
- Tension intensified between FTC regulators and the advertising industry over the proper limits of online tracking.
- The Securities and Exchange Commission (SEC) approved new rules under the JOBS Act meant to facilitate IPOs for smaller companies.
- The SEC proposed new swap rules and invited public comments.
- Various regulators from around the world expressed concerns about Google’s privacy policy, but the U.S. FTC opted not to join.
- The Federal Communications Commission (FCC) approved a proposal to allow AT&T to expand broadband services into a disputed portion of wireless spectrum.
- Industry group claimed that newly minted U.S. regulations have slowed the rate of derivatives trading across Asia.
